Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Junghans

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Science (New York, N.Y.)|April 4, 1980
Mercury in the oceanR P Junghans
Immunologic Research|February 1, 1997
Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgGR P Junghans
Trends in Biotechnology|May 1, 1997
Next-generation Fc chimeric proteins: avoiding immune-system interactionsR P Junghans
Immunopharmacology|September 21, 2000
Interleukin 2 maintains biologic stability and sterility over prolonged timeM Safar, R P Junghans
Immunology|July 11, 2000
The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bileP Telleman, R P Junghans
Proceedings of the National Academy of Sciences of the United States of America|May 28, 1996
The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptorR P Junghans, C L Anderson
Journal of Immunological Methods|November 27, 1998
Measurement and biological correlates of antibody bioactivity during antibody immunotherapiesD S Hagg, R P Junghans
The Journal of Experimental Medicine|April 1, 1996
Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody bindingR P Junghans, T A Waldmann
Methods in Enzymology|July 26, 2000
Ultracentrifugal analysis of molecular mass of glycoproteins of unknown or ill-defined carbohydrate compositionM S Lewis, R P Junghans
The American Journal of Medicine|March 30, 1984
High-dose intravenous gamma globulin to suppress alloimmune destruction of donor plateletsR P Junghans, Y S Ahn
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Science (New York, N.Y.)|April 4, 1980
Mercury in the oceanR P Junghans
Immunologic Research|February 1, 1997
Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgGR P Junghans
Trends in Biotechnology|May 1, 1997
Next-generation Fc chimeric proteins: avoiding immune-system interactionsR P Junghans
Immunopharmacology|September 21, 2000
Interleukin 2 maintains biologic stability and sterility over prolonged timeM Safar, R P Junghans
Immunology|July 11, 2000
The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bileP Telleman, R P Junghans
Proceedings of the National Academy of Sciences of the United States of America|May 28, 1996
The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptorR P Junghans, C L Anderson
Journal of Immunological Methods|November 27, 1998
Measurement and biological correlates of antibody bioactivity during antibody immunotherapiesD S Hagg, R P Junghans
The Journal of Experimental Medicine|April 1, 1996
Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody bindingR P Junghans, T A Waldmann
Methods in Enzymology|July 26, 2000
Ultracentrifugal analysis of molecular mass of glycoproteins of unknown or ill-defined carbohydrate compositionM S Lewis, R P Junghans
The American Journal of Medicine|March 30, 1984
High-dose intravenous gamma globulin to suppress alloimmune destruction of donor plateletsR P Junghans, Y S Ahn
Pageof 7